EUVIMEDEUVIMED entdecken
Open Access

The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2–Infected Individuals with Severe Disease

Suguru Saito iD, Najmeh Bozorgmehr, Wendy Sligl, Mohammed Osman, Shokrollah Elahi iD

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2300783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Suguru Saito und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe SARS-CoV-2 infection is associated with significant immune dysregulation involving different immune cell subsets. In this study, when analyzing critically ill COVID-19 patients versus those with mild disease, we observed a significant reduction in total and memory B cell subsets but an increase in naive B cells. Moreover, B cells from COVID-19 patients displayed impaired effector functions, evidenced by diminished proliferative capacity, reduced cytokine, and Ab production. This functional impairment was accompanied by an increased apoptotic potential upon stimulation in B cells from severely ill COVID-19 patients. Our further studies revealed the expansion of B cells expressing coinhibitory molecules (PD-1, PD-L1, TIM-1, VISTA, CTLA-4, and Gal-9) in intensive care unit (ICU)–admitted patients but not in those with mild disease. The coinhibitory receptor expression was linked to altered IgA and IgG expression and increased the apoptotic capacity of B cells. Also, we found a reduced frequency of CD24hiCD38hi regulatory B cells with impaired IL-10 production. Our mechanistic studies revealed that the upregulation of PD-L1 was linked to elevated plasma IL-6 levels in COVID-19 patients. This implies a connection between the cytokine storm and altered B cell phenotype and function. Finally, our metabolomic analysis showed a significant reduction in tryptophan but elevation of kynurenine in ICU-admitted COVID-19 patients. We found that kynurenine promotes PD-L1 expression in B cells, correlating with increased IL-6R expression and STAT1/STAT3 activation. Our observations provide novel insights into the complex interplay of B cell dysregulation, implicating coinhibitory receptors, IL-6, and kynurenine in impaired B cell effector functions, potentially contributing to the pathogenesis of COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansMaleMiddle AgedFemaleAgedB-LymphocytesB-Lymphocyte SubsetsSeverity of Illness IndexAdultApoptosisCritical IllnessInterleukin-10Programmed Cell Death 1 ReceptorInterleukin-6

Substanzen

Interleukin-10Programmed Cell Death 1 ReceptorInterleukin-6

Autor:innen und Institutionen

  • School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, AB, Canada.
  • Department of Critical Care Medicine, University of Alberta, Edmonton, AB, Canada.
  • Department of Medicine, Division of Infectious Diseases, University of Alberta, Edmonton, AB, Canada.
  • Department of Medicine, Division of Rheumatology, University of Alberta, Edmonton, AB, Canada.
  • Department of Oncology, University of Alberta, Edmonton, AB, Canada.
  • Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.

ORCID-Profile: Suguru Saito, Shokrollah Elahi

Förderung

  • Canadian Government | Canadian Institutes of Health Research (CIHR)

Zitieren

APA

Saito, S., Bozorgmehr, N., Sligl, W., Osman, M., & Elahi, S. (2024). The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2–Infected Individuals with Severe Disease. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300783

Vancouver

Saito S, Bozorgmehr N, Sligl W, Osman M, Elahi S. The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2–Infected Individuals with Severe Disease. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300783

BibTeX
@article{Saito2024,
  author = {Saito, Suguru and Bozorgmehr, Najmeh and Sligl, Wendy and Osman, Mohammed and Elahi, Shokrollah},
  title = {The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2–Infected Individuals with Severe Disease},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2300783}
}
Kostenlos starten →